Bio-Rad Labs Inc. A buy Royal Bank of Canada
Start price
16.08.24
/
50%
€292.30
Target price
16.08.25
€364.63
Performance (%)
-27.23%
Price
15.07.25
€213.30
Summary
This prediction is currently active. The prediction for Bio-Rad Labs Inc. A disappoints with a performance of -27.23%. This prediction currently runs until 16.08.25. The prediction end date can be changed by Royal_Bank_of_Canada at any time. Royal_Bank_of_Canada has 50% into this predictionPerformance without dividends (%)
Name | 1w | 1m |
---|---|---|
Bio-Rad Labs Inc. A | 1.090% | 1.090% |
iShares Core DAX® | -0.727% | 2.783% |
iShares Nasdaq 100 | 1.839% | 5.294% |
iShares Nikkei 225® | -2.033% | -0.196% |
iShares S&P 500 | 1.334% | 4.044% |
Comments by Royal_Bank_of_Canada for this prediction
In the thread Bio-Rad Labs Inc. A diskutieren
Bio-Rad Laboratories, Inc. (NYSE: BIO) had its "outperform" rating re-affirmed by analysts at Royal Bank of Canada. They now have a $401.00 price target on the stock.
Ratings data for BIO provided by MarketBeat
Stopped prediction by Royal_Bank_of_Canada for Bio-Rad Labs Inc. A
Bio-Rad Labs Inc. A
Start price
Target price
Perf. (%)
€209.20
02.05.25
02.05.25
€347.08
02.05.26
02.05.26
1.96%
15.07.25
15.07.25
Bio-Rad Labs Inc. A
Start price
Target price
Perf. (%)
€331.60
14.01.25
14.01.25
€467.48
14.01.26
14.01.26
-35.68%
15.07.25
15.07.25
Bio-Rad Labs Inc. A
Start price
Target price
Perf. (%)
€315.50
09.12.24
09.12.24
€454.64
09.12.25
09.12.25
-32.39%
15.07.25
15.07.25
Bio-Rad Labs Inc. A
Start price
Target price
Perf. (%)
€329.60
31.10.24
31.10.24
€431.06
31.10.25
31.10.25
-35.29%
15.07.25
15.07.25
Bio-Rad Labs Inc. A
Start price
Target price
Perf. (%)
€307.80
02.08.24
02.08.24
€367.36
02.08.25
02.08.25
-30.70%
15.07.25
15.07.25
Bio-Rad Labs Inc. A
Start price
Target price
Perf. (%)
€316.20
16.02.24
16.02.24
€445.58
16.02.25
16.02.25
-15.75%
17.02.25
17.02.25
Bio-Rad Labs Inc. A
Start price
Target price
Perf. (%)
€363.40
04.08.23
04.08.23
€474.64
04.08.24
04.08.24
-17.06%
05.08.24
05.08.24